Search Results 101-110 of 16914 for Antagonist

1. A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer - Mayo Clinic

   Currently using a GnRH agonist or antagonist (unless surgically castrated). Exclusion Criteria: Cancer-related pain requiring scheduled opioid narcotics for ...

2. A Phase 3 Study To Examine The Effectiveness, Safety And Tolerability Of APL-130277 For The Acute Treatment Of Motor Fluctuation Episodes In Patients With Parkinson's Disease - Mayo Clinic

   Selective 5HT3 antagonists (i.e., ondansetron, granisetron, dolasetron, palonosetron, alosetron); Dopamine antagonists (excluding quetiapine or clozapine) ...

3. A Study Of Latanoprost In Open Angle Glaucoma And Ocular Hypertension Patients - Mayo Clinic

   ... antagonists, α-adrenergic agonists and antagonists, angiotensin converting enzyme (ACE) inhibitors, angiotensin II receptor blockers. Recent change in ...

4. Publications - Anastasia Zekeridou, M.D., Ph.D. - Mayo Clinic

   ... antagonist. Epilepsia. 2021 Mar; 62 (3):671-682 Epub 2021 Feb 17. View PubMed; Budhram A, Sechi E, Flanagan EP, Dubey D, Zekeridou A, Shah SS, Gadoth A ...

5. Vedolizumab IV 300 Mg In The Treatment Of Fistulizing Crohn's Disease - Mayo Clinic

   ... antagonist for their underlying CD (does not require treatment failure for currently active draining fistula). France only: The participant, historically ...

6. Trial To Evaluate Anticoagulation Therapy In Hemodialysis Patients With Atrial Fibrillation - Mayo Clinic

   Need for aspirin at a dose > 81 mg a day or need for P2Y12 antagonist therapy (for example clopidogrel, prasugrel, or ticagrelor); Life expectancy < 3 months ...

7. Outcomes of Percutaneous Revascularization for Management of Surgically Ineligible Patients With Multivessel or Left Main Coronary Artery Disease: A Prospective Registry - Mayo Clinic

   Established iodine allergy that cannot be managed medically, allergy to everolimus, or absolute contraindication to aspirin, P2Y12 antagonist therapy with ...

8. Iron Sucrose in Adolescents With Iron Deficiency and Postural Orthostatic Tachycardia Syndrome (POTS) - Mayo Clinic

   ... antagonists unless medication is held for five half-lives prior to study; laboratory evidence of significant anemia, as defined by a hemoglobin level 1 gm/dL ...

9. Circulating NEP and NEP Inhibition Study in Heart Failure With Preserved Ejection Fraction - Mayo Clinic

   ... antagonists;; No change in dosage of ACE, ARBs, beta-blockers, CCBs or aldosterone antagonists of more than 100%. Elevated NT-proBNP (>300 pg/ml) or BNP ...

10. A Study To Examine The Long-Term Safety, Tolerability And Effectiveness Of APL-130277 For The Acute Treatment Of "OFF" Episodes In Patients With Parkinson's Disease - Mayo Clinic

    ... antagonists (excluding quetiapine and clozapine) or dopamine depleting agents; Drug or alcohol dependency in the past 12 months; History of malignant melanoma ...